1. Assessing the risks of estrogen replacement therapy

   Newsletter Article 08 February 2013 Pages: 2 - 2

2. Clonidine-induced myalgia

   Newsletter Article 08 February 2013 Pages: 2 - 2

3. Adverse effects of abrupt drug withdrawal

   Newsletter Article 08 February 2013 Pages: 2 - 3

4. Monitoring over-the-counter drug use

   Newsletter Article 08 February 2013 Pages: 3 - 3

5. Halothane hepatitis

   Newsletter Article 08 February 2013 Pages: 3 - 3

6. Alcohol interaction see Amitriptyline interaction

   Newsletter Article 08 February 2013 Pages: 4 - 4

7. Amitriptyline interaction

   Newsletter Article 08 February 2013 Pages: 4 - 4

8. Antidepressants

   Newsletter Article 08 February 2013 Pages: 4 - 4

9. Antithymocyte globulin

   Newsletter Article 08 February 2013 Pages: 5 - 5

10. Atrial natriuretic factor

    Newsletter Article 08 February 2013 Pages: 5 - 5

11. Barium sulfate interaction

    Newsletter Article 08 February 2013 Pages: 5 - 5

12. Beclomethasone

    Newsletter Article 08 February 2013 Pages: 5 - 5

13. Caffeine

    Newsletter Article 08 February 2013 Pages: 5 - 5

14. Calcitriol

    Newsletter Article 08 February 2013 Pages: 5 - 6

15. Captopril see Pyritinol/captopril

    Newsletter Article 08 February 2013 Pages: 6 - 6

16. Cimetidine

    Newsletter Article 08 February 2013 Pages: 6 - 6

17. Clomipramine interaction

    Newsletter Article 08 February 2013 Pages: 6 - 6

18. Cocaine abuse

    Newsletter Article 08 February 2013 Pages: 6 - 7

19. Coiestipol/nicotinic acid

    Newsletter Article 08 February 2013 Pages: 7 - 7

20. Corbadrine see Mepivacaine

    Newsletter Article 08 February 2013 Pages: 7 - 7

21. Cyclosporin interaction

    Newsletter Article 08 February 2013 Pages: 7 - 7

22. Desipramine

    Newsletter Article 08 February 2013 Pages: 7 - 7

23. Desipramine interaction

    Newsletter Article 08 February 2013 Pages: 7 - 7

24. Diazepam withdrawal

    Newsletter Article 08 February 2013 Pages: 7 - 8

25. Diuretics

    Newsletter Article 08 February 2013 Pages: 8 - 8

26. Electroconvulsive therapy see Lithium interaction

    Newsletter Article 08 February 2013 Pages: 8 - 8

27. Erythromycin

    Newsletter Article 08 February 2013 Pages: 8 - 8

28. Estrogen

    Newsletter Article 08 February 2013 Pages: 8 - 9

29. Etretinate

    Newsletter Article 08 February 2013 Pages: 9 - 9

30. Flupenthixol interaction see Clomipramine interaction

    Newsletter Article 08 February 2013 Pages: 9 - 9

31. Glucagon see Barium sulfate

    Newsletter Article 08 February 2013 Pages: 9 - 9

32. Haloperidol interaction see Desipramine interaction

    Newsletter Article 08 February 2013 Pages: 9 - 9

33. Hetastarch

    Newsletter Article 08 February 2013 Pages: 9 - 9

34. Ifosfamide interaction

    Newsletter Article 08 February 2013 Pages: 9 - 9

35. Isoflurane

    Newsletter Article 08 February 2013 Pages: 9 - 9

36. Itraconazole see Cyclosporin interaction

    Newsletter Article 08 February 2013 Pages: 10 - 10

37. Lithium

    Newsletter Article 08 February 2013 Pages: 10 - 10

38. Lithium interaction

    Newsletter Article 08 February 2013 Pages: 10 - 10

39. Mefenamic acid overdose

    Newsletter Article 08 February 2013 Pages: 10 - 10

40. Mepivacaine/corbadrine

    Newsletter Article 08 February 2013 Pages: 10 - 11

41. Mesna interaction see Ifosfamide interaction

    Newsletter Article 08 February 2013 Pages: 11 - 11

42. Methanol

    Newsletter Article 08 February 2013 Pages: 11 - 11

43. Methylprednisolone

    Newsletter Article 08 February 2013 Pages: 11 - 11

44. Metoclopramide

    Newsletter Article 08 February 2013 Pages: 11 - 12

45. Mianserin

    Newsletter Article 08 February 2013 Pages: 12 - 12

46. Morphine

    Newsletter Article 08 February 2013 Pages: 12 - 12

47. Nicotinic acid see Colestipol/nicotinic acid

    Newsletter Article 08 February 2013 Pages: 12 - 12

48. Oxymetholone

    Newsletter Article 08 February 2013 Pages: 12 - 12

49. Papaverine/phentolamine

    Newsletter Article 08 February 2013 Pages: 12 - 12

50. Penicillamine

    Newsletter Article 08 February 2013 Pages: 12 - 12